Document Detail

Novel therapy for myocardial infarction: can HGF/Met be beneficial?
MedLine Citation:
PMID:  21327916     Owner:  NLM     Status:  MEDLINE    
Myocardial infarction (MI) is a leading cause of hospitalization worldwide. A recently developed strategy to improve the management of MI is based on the use of growth factors which are able to enhance the intrinsic capacity of the heart to repair itself or regenerate after damage. Among others, hepatocyte growth factor (HGF) has been proposed as a modulator of cardiac repair of damage due to the pleiotropic effects elicited by Met receptor stimulation. In this review we describe the mechanistic basis for autocrine and paracrine protection of HGF in the injured heart. We also analyse the role of HGF/Met in stem cell maintenance and in stem cell therapies for MI. Finally, we summarize the most significant results on the use of HGF in experimental models of heart injury and discuss the potential of the molecule for treating ischaemic heart disease in humans.
V Sala; T Crepaldi
Related Documents :
7742986 - Mitral allograft with chordal support: echocardiographic evaluation in sheep.
19032916 - Surgical therapy for mitral regurgitation: the key to preventing heart failure?
10096476 - Morphologic findings in explanted hancock ii porcine bioprostheses.
7003386 - Decreased myocardial taurine levels and hypertaurinuria in a kindred with mitral-valve ...
12152816 - Giant right atrial diverticulum in a foal.
18522736 - Suspected association of ventricular arrhythmia with air pollution in a motorbike rider...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review     Date:  2011-02-17
Journal Detail:
Title:  Cellular and molecular life sciences : CMLS     Volume:  68     ISSN:  1420-9071     ISO Abbreviation:  Cell. Mol. Life Sci.     Publication Date:  2011 May 
Date Detail:
Created Date:  2011-04-18     Completed Date:  2011-06-20     Revised Date:  2012-06-04    
Medline Journal Info:
Nlm Unique ID:  9705402     Medline TA:  Cell Mol Life Sci     Country:  Switzerland    
Other Details:
Languages:  eng     Pagination:  1703-17     Citation Subset:  IM    
Department of Anatomy, Pharmacology and Forensic Medicine, University of Turin, Corso Massimo D'Azeglio 52, 10126, Turin, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Gene Therapy
Hepatocyte Growth Factor / genetics,  physiology*,  therapeutic use
Myocardial Infarction / physiopathology,  therapy*
Paracrine Communication
Proto-Oncogene Proteins c-met / genetics,  metabolism,  physiology*
Receptors, Growth Factor / genetics,  metabolism,  physiology*
Stem Cells / cytology,  metabolism
Reg. No./Substance:
0/Receptors, Growth Factor; 67256-21-7/Hepatocyte Growth Factor; EC protein, human; EC Proteins c-met

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  What's the hype about CDK5RAP2?
Next Document:  Proximal and overall gastric emptying of solids in patients with reduced gastric volume accommodatio...